日本ケミファ(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証STD | 医薬品 | 4539/E00957 | NIPPON CHEMIPHAR CO., LTD. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2023/08/18 | 日証協 | 55,838株 | +0.6% | 8,648株 | +25.04% | 71,162株 | +0.57% | 19,705株 | -9.19% |
| 2023/08/10 | 日証協 | 55,505株 | +0.6% | 6,916株 | +0.16% | 70,758株 | +2.12% | 21,700株 | -23.24% |
| 2023/08/04 | 日証協 | 55,176株 | +2.04% | 6,905株 | +1992.42% | 69,288株 | +0.59% | 28,270株 | -0.43% |
| 2023/07/28 | 日証協 | 54,072株 | -4.08% | 330株 | -79.38% | 68,883株 | -2.96% | 28,392株 | +62.07% |
| 2023/07/21 | 日証協 | 56,372株 | -2.76% | 1,600株 | -91.93% | 70,985株 | -6.75% | 17,518株 | +26.98% |
| 2023/07/14 | 日証協 | 57,972株 | -1.48% | 19,828株 | +3052.31% | 76,124株 | +2.28% | 13,796株 | +17.91% |
| 2023/07/07 | 日証協 | 58,844株 | +4.44% | 629株 | -90.17% | 74,424株 | +2.16% | 11,700株 | -34.27% |
| 2023/06/30 | 日証協 | 56,344株 | +5.43% | 6,400株 | +357.14% | 72,852株 | +4.84% | 17,801株 | -8.69% |
| 2023/06/23 | 日証協 | 53,444株 | -0.37% | 1,400株 | +55.56% | 69,489株 | +0.87% | 19,495株 | +24.84% |
| 2023/06/16 | 日証協 | 53,644株 | -0.92% | 900株 | +50% | 68,888株 | -0.7% | 15,616株 | -18.28% |
| 2023/06/09 | 日証協 | 54,144株 | -1.1% | 600株 | -76% | 69,372株 | -7.1% | 19,108株 | +57.68% |
| 2023/06/02 | 日証協 | 54,744株 | +4.79% | 2,500株 | +4.17% | 74,670株 | +1.8% | 12,118株 | -35.52% |
| 2023/05/26 | 日証協 | 52,244株 | -2.43% | 2,400株 | +500% | 73,352株 | +4.26% | 18,793株 | -9.22% |
| 2023/05/19 | 日証協 | 53,544株 | -1.29% | 400株 | 0% | 70,353株 | -1.26% | 20,701株 | -0.48% |
| 2023/05/12 | 日証協 | 54,244株 | -2.52% | 400株 | 0% | 71,252株 | -2.6% | 20,801株 | +114.58% |
| 2023/05/02 | 日証協 | 55,644株 | -12.16% | 0株 | -100% | 73,151株 | -9.4% | 9,694株 | -54.08% |
| 2023/04/28 | 日証協 | 63,347株 | -4.09% | 200株 | 0% | 80,744株 | -3.93% | 21,110株 | -11.73% |
| 2023/04/21 | 日証協 | 66,047株 | -1.3% | 200株 | -99.56% | 84,044株 | -1.14% | 23,914株 | +67.23% |
| 2023/04/14 | 日証協 | 66,918株 | +1.24% | 45,400株 | +1330.82% | 85,015株 | -3.95% | 14,300株 | +91.64% |
※株式分割は考慮していませんのでご注意ください。